Long-term salvage therapy with cyclosporin A in refractory idipathic thrombocytopenic purpura

Blood

Volumn 99, Issue 4, 2002, Pages 1482-1485

  Emilia, Giovanni ^a,b   Morselli, Monica ^a   Luppi, Mario ^a   Longo, Giuseppe ^a   Marasca, Roberto ^a   Gandini, Giovanna ^a   Ferrara, Leonardo ^a   D'Apollo, Nicola ^a   Potenza, Leonardo ^a   Bertesi, Marcello ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSPEPSIA; FATIGUE; FEMALE; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAINTENANCE THERAPY; MALE; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; REMISSION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0037082457     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.4.1482     Document Type: Article

References (23)

1. Chronic idiopathic thrombocytopenic purpura
2. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
3. Treatment of refractory idiopathic thrombocytopenic purpura in adults
4. Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin
5. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: An update
6. Long-term outcomes after treatment for refractory immune thrombocytopenic purpura
7. Humanized monoclonal anti-CD40 ligand antibody (hu5c8) rescue therapy of 15 adults with severe chronic refractory ITP
8. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
9. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura
10. Idiopathic thrombocytopenic purpura in the older adult patient
11. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura
12. Cyclosporine for the treatment of refractory idiopathic thrombocytopenic purpura
13. Management of chronic immune thrombocytopenic purpura in children and adults
14. Longterm salvage treatment by cyclosporin in refractory autoimmune haematological disorders
15. Refractory idiopathic thrombocytopenic purpura (ITP) treated with cyclosporine
16. Low dose cyclosporine is beneficial in treating refractory ITP
17. Fate of therapy failures in adult idiopathic thrombocytopenic purpura
18. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
19. Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy
20. Cyclosporine
21. Longterm maintenance of therapeutic cyclosporine levels leads to optimal graft survival without evidence of chronic nephrotoxicity
22. Long-term efficacy and safety of cyclosporine in renal-transplant recipients